BioSpace News Archive

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) today announced the clearance of investigational new drug (IND) applications for [225Ac]-FPI-2068 (FPI-2068) and corresponding imaging analogue [111In]-FPI-2107 (FPI-2107) to the U.S. Food and Drug Administration (FDA).

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Jacob Liawatidewi, EVP of Corporate Administration, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on April 19th, 2023 at 12:45 pm Eastern Time.

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2023 after market close on Tuesday, May 2, 2023.

PLx Pharma Inc., is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE®, an FDA-approved liquid-filled aspirin capsule, available in 81 mg and 325 mg doses.

With an increasing number of scientists raising their concerns over research on exotic viruses worldwide and the debate on SARS-CoV-2’s origin still raging, AIDS Healthcare Foundation (AHF) urges all countries to promote international transparency and strict oversight on work with highly-contagious, pandemic-capable viruses.

Ceapro Inc.(TSX-V: CZO, OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced operational highlights and financial results for the fourth quarter and full year ended December 31, 2022.

Celularity Inc. announced that Robert Hariri, M.D., Ph.D., Celularity’s Chief Executive Officer, Chairman and Founder, will kick off the International Precision Medicine Center Conference, April 11-12th, in Goyang City, Republic of Korea, delivering the keynote address together with Scott Gottlieb, M.D., Senior Fellow of the American Enterprise Institute and former Commissioner of the U.S. Food and Drug Administration.

Bloomage Biotech released its 2022 Financial Report on March 30, 2023, posting a revenue of $924 million, an increase of 28.53% year-over-year.

Centinel Spine®, LLC, (“the Company”) today announced record fourth quarter 2022 revenue achievement driven by growth in the Company’s Motion Preservation business and early adoption of the recently launched prodisc C Vivo and prodisc C SK cervical total disc replacement (TDR) system.

Panavance Therapeutics Inc. announced that Greg Bosch, Chairman and CEO of Panavance Therapeutics will present at BioNJ’s Thirteenth Annual BioPartnering Conference on Tuesday, April 18, 2023 at 10:20 AM ET in Somerset, NJ.